U.S. flag

An official website of the United States government

NM_005343.4(HRAS):c.182_183delinsGA (p.Gln61Arg) AND Neoplasm

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 14, 2015
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000418005.1

Allele description [Variation Report for NM_005343.4(HRAS):c.182_183delinsGA (p.Gln61Arg)]

NM_005343.4(HRAS):c.182_183delinsGA (p.Gln61Arg)

Genes:
HRAS:HRas proto-oncogene, GTPase [Gene - OMIM - HGNC]
LRRC56:leucine rich repeat containing 56 [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
11p15.5
Genomic location:
Preferred name:
NM_005343.4(HRAS):c.182_183delinsGA (p.Gln61Arg)
HGVS:
  • NC_000011.10:g.533873_533874delinsTC
  • NG_007666.1:g.6677_6678delinsGA
  • NM_001130442.3:c.182_183delinsGA
  • NM_001318054.2:c.-138_-137delinsGA
  • NM_005343.4:c.182_183delinsGAMANE SELECT
  • NM_176795.5:c.182_183delinsGA
  • NP_001123914.1:p.Gln61Arg
  • NP_005334.1:p.Gln61Arg
  • NP_789765.1:p.Gln61Arg
  • LRG_506t1:c.182_183delinsGA
  • LRG_506:g.6677_6678delinsGA
  • LRG_506p1:p.Gln61Arg
  • NC_000011.9:g.533873_533874delinsTC
Protein change:
Q61R
Links:
dbSNP: rs1057519855
NCBI 1000 Genomes Browser:
rs1057519855
Molecular consequence:
  • NM_001318054.2:c.-138_-137delinsGA - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001130442.3:c.182_183delinsGA - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005343.4:c.182_183delinsGA - missense variant - [Sequence Ontology: SO:0001583]
  • NM_176795.5:c.182_183delinsGA - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neoplasm
Synonyms:
Neoplasms; Neoplasm (disease)
Identifiers:
MONDO: MONDO:0005070; MeSH: D009369; MedGen: C0027651; Human Phenotype Ontology: HP:0002664

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000505658Database of Curated Mutations (DoCM)
no assertion criteria provided
Likely pathogenic
(Jul 14, 2015) 		somaticliterature only

PubMed (1)
[See all records that cite this PMID]

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

MacConaill LE, Garcia E, Shivdasani P, Ducar M, Adusumilli R, Breneiser M, Byrne M, Chung L, Conneely J, Crosby L, Garraway LA, Gong X, Hahn WC, Hatton C, Kantoff PW, Kluk M, Kuo F, Jia Y, Joshi R, Longtine J, Manning A, Palescandolo E, et al.

J Mol Diagn. 2014 Nov;16(6):660-72. doi: 10.1016/j.jmoldx.2014.06.004. Epub 2014 Aug 23.

PubMed [citation]
PMID:
25157968
PMCID:
PMC4210463

Details of each submission

From Database of Curated Mutations (DoCM), SCV000505658.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 26, 2023